Series B - Kira Pharmaceuticals
Investment Firm
Overview
Kira Pharmaceuticals is a Biotechnology Research Company.
Announced Date
Jan 07, 2021
Funding Type
Series B
Highlights
Location
Asia
Social
N/A
Investor Lead
Vivo Capital
Vivo Capital is a early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.
RA Capital Management
RA Capital Management is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.
Participant Investors
4
Round Details and Background
Kira Pharmaceuticals raised $53500000 on 2021-01-07 in Series B
Kira Pharmaceuticals is a Biotechnology Research Company.
Company Funding History
5
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jul 01, 2017 |  Series A - Kira Pharmaceuticals | 1 | - | 5.0M |
| Feb 01, 2020 | Series B - Kira Pharmaceuticals | 1 | - | 28.0M |
| Jan 07, 2021 | Series B - Kira Pharmaceuticals | 6 | - | 53.5M |
| Nov 16, 2020 | Venture Round - Kira Pharmaceuticals | 4 | - | undefined |
Recent Activity
There is no recent news or activity for this profile.